Solventum (MIL:1SOLV) Total Equity: €4,299 Mil (As of Mar. 2026)


MIL:1SOLV Solventum Corp MIL:1SOLV
24 GF Score
Price €65.00
! 8 Warning Signs
View Full Analysis

What is Solventum Total Equity?

Solventum MIL:1SOLV 24 Total Equity is €4,299 Mil as of Mar. 2026. GuruFocus rates MIL:1SOLV with a GF Score™ of 24/100. The stock has 8 warning signs investors should review.

Solventum's total equity for the quarter that ended in Mar. 2026 was €4,299 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Solventum Total Equity Historical Data

* Premium members only.

The historical data trend for Solventum's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solventum Total Equity Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 10,672.22 11,084.45 10,697.72 2,825.85 4,312.70

Solventum Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,017.35 3,160.22 4,248.07 4,312.70 4,299.05
MIL:1SOLV
24GF Score
Solventum Corp MIL:1SOLV
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solventum Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Solventum's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=12207.076-7894.376
=4,313

Solventum's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=12193.905-7894.855
=4,299

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €4,299 Mil mean?
Solventum (MIL:1SOLV) has a Total Equity of €4,299 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Solventum and its competitors.
Is Solventum's Total Equity too high?
Solventum's current Total Equity is €4,299 Mil. Overall, Solventum has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Solventum's Total Equity compare to COO and ALGN?
Solventum's Total Equity of €4,299 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Solventum and its competitors. Solventum's current Total Equity is €4,299 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solventum stock overvalued right now?
Solventum (MIL:1SOLV) has a current Total Equity of €4,299 Mil. The current Total Equity is €4,299 Mil. Solventum's overall GF Score™ is 24/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Solventum (MIL:1SOLV), the current Total Equity is €4,299 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Solventum Business Description

Address 2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
24GF Score

Get the complete analysis for MIL:1SOLV

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.00
Price